- Threads: 17
- Posts: 2773
Melissa Healy, Amina Khanlink to original post
Fri, September 17, 2021, 8:47 PM
Amid persistent concerns that the protection offered by COVID-19 vaccines may be waning, a report released Friday by the Centers for Disease Control and Prevention finds that America's workhorse shot is significantly less effective at preventing severe cases of disease over the long term than many experts had realized.
Data collected from 18 states between March and August suggest the Pfizer-BioNTech vaccine reduces the risk of being hospitalized with COVID-19 by 91% in the first four months after receiving the second dose. Beyond 120 days, however, that vaccine efficacy drops to 77%.
Meanwhile, Moderna's vaccine was 93% effective at reducing the short-term risk of COVID-19 hospitalization and remained 92% effective after 120 days.
The strong divide between the FDA panel and Pfizer/Fauci on approving a “booster shot” was the eye raising and concerning part of the article for me, certainly makes it rather ambiguous for those not considered at elevated risk of severe illness to make an informed decision. FDA overwhelmingly voted against full approval of a third shot for all 16+ adults by a vote of 16-2, citing the need for more age specific data to be presented regarding safety. They did unanimously vote to recommend it for 65+, and other elevated risk categories.
Commenting on not approving it beforehand being a “mistake” by someone in Fauci’s position seems a bit like meddling, undermining credibility of and trying to influence what’s supposed to be an independent decision but whatever.